Montelukast sodium (Macleods Pharmaceuticals Limited)


Welcome to the PulseAid listing for the Montelukast sodium drug offered from Macleods Pharmaceuticals Limited. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Macleods Pharmaceuticals Limited
NON-PROPRIETARY NAME: Montelukast sodium
SUBSTANCE NAME: MONTELUKAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-04-01
END MARKETING DATE: 0000-00-00


Montelukast sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMontelukast sodium from Macleods Pharmaceuticals Limited
LABELER NAME: Macleods Pharmaceuticals Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/1)
START MARKETING DATE: 2014-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 33342-110_3d5ccdc5-b890-44b3-9104-baa689e6f33c
PRODUCT NDC: 33342-110
APPLICATION NUMBER: ANDA203582

Other MONTELUKAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Camber Pharmaceuticals, Inc.montelukast sodium
Macleods Pharmaceuticals LimitedMontelukast sodium